Hepatocellular carcinoma is a leading cancer worldwide. Its incidence is increasing, and is
closely related to advanced liver disease. Cirrhosis represents the greatest risk factor for this …

Hepatocellular carcinoma (HCC) is the seventh most common cancer worldwide and the
third most common cause of cancer-related deaths; the number of new cases per year is …

This practice guideline has been approved by the American Association for the Study of
Liver Diseases and the American Society of Transplantation. These recommendations …

Background Patients undergoing liver transplantation for hepatocellular carcinoma within
the Milan criteria (single tumour≤ 5 cm in size or≤ 3 tumours each≤ 3 cm in size, and no …

Hepatocellular carcinoma (HCC) is one of the most common cancers in the world, and
cirrhosis is a risk factor for HCC. Resection is indicated for those unilobar tumors without …

Intended for use by physicians, these recommendations suggest preferred approaches to
the diagnostic, therapeutic, and preventive aspects of care. They are intended to be flexible …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide with a poor
prognosis and one for which immunotherapy remains a viable option. Experimental tumor …

We previously suggested that in patients with heptocellular carcinoma (HCC), the
conventional Milan criteria (T1/T2) for orthotopic liver transplantation (OLT) could be …

Background: The Milan criteria have been adopted by United Network for Organ Sharing
(UNOS) to preoperatively assess outcome in patients with hepatocellular carcinoma (HCC) …

Background and Aims Radioembolization (yttrium‐90 [Y90]) is used in hepatocellular
carcinoma (HCC) as a bridging as well as downstaging liver‐directed therapy to curative …